换一批
换一批A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤药, 植物(Antineoplastic Agents, Phytogenic);喜树碱(Camptothecin);结直肠肿瘤(Colorectal Neoplasms);疾病恶化(Disease Progression);用药计划表(Drug Administration Schedule);酶抑制剂(Enzyme Inhibitors);女(雌)性(Female);人类(Humans);输注, 静脉内(Infusions, Intravenous);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);胸苷酸合酶(Thymidylate Synthase)
DOI
10.1200/JCO.2004.01.005
PMID
15284252
发布时间
2018-11-30
- 浏览16
Journal of clinical oncology
3023-31页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
